MedPath

The respiratory depression of concomitant infusion of remimazolam and remifentanil using targeting effect-site concentrations

Not Applicable
Active, not recruiting
Conditions
Factors influencing health status and contact with health services
Registration Number
KCT0009178
Lead Sponsor
Ajou University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Active, not recruiting
Sex
Female
Target Recruitment
108
Inclusion Criteria

Patients aged 20-70 with American Society of Anesthesiologists (ASA) physical status classification of 2 or below, undergoing general anesthesia for scheduled gynecological surger

Exclusion Criteria

Patients with a BMI of 30 or higher, predicted difficult airway with Mallampatti class 3 or 4, presence of sleep apnea, history of lung disease, recent upper respiratory infection within the last 3 weeks, liver disorder (AST or ALT = 100 U/L), and renal impairment (serum creatinine = 2 mg/dL)

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The frequency of loss of consciousness
Secondary Outcome Measures
NameTimeMethod
The frequency of jaw thrust;The frequency of adminitrating 100% oxygen;The frequency of assist ventilation;tidal volulme;minute ventilation;time for loss of consciousness
© Copyright 2025. All Rights Reserved by MedPath